Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials)Véronique Crutel, Bruno Falissard, Pierre‐François Pénélaud et al.|Journal of Autism and Developmental Disorders|2020Cited by 38
P.809 Correlation between childhood autism rating scale 2 and clinical global impression improvementB. Falissard, Éric Lemonnier, Simon Kyaga et al.|European Neuropsychopharmacology|2019Cited by 2